Maternal and neonatal outcomes after antepartum treatment of influenza with antiviral medications

Obstetrics and Gynecology

Volumn 115, Issue 4, 2010, Pages 711-716

  Greer, Laura G ^a   Sheffield, Jeanne S ^a   Rogers, Vanessa L ^a   Roberts, Scott W ^a   McIntire, Donald D ^a   Wendel, George D ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; ANTIVIRUS AGENT; M2 ION CHANNEL INHIBITOR; OSELTAMIVIR; RIMANTADINE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ANTIVIRAL THERAPY; ARTICLE; BRAIN HEMORRHAGE; COHORT ANALYSIS; CONTROLLED STUDY; DRUG SAFETY; FEMALE; FETUS MALFORMATION; FETUS OUTCOME; FETUS WEIGHT; HUMAN; HYPERBILIRUBINEMIA; INCIDENCE; INFLUENZA; INTUBATION; LENGTH OF STAY; LIVE BIRTH; MAJOR CLINICAL STUDY; NECROTIZING ENTEROCOLITIS; NEWBORN; NEWBORN DEATH; NEWBORN INTENSIVE CARE; NEWBORN MORTALITY; PREECLAMPSIA; PREGNANCY; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEIZURE; SIDE EFFECT; STILLBIRTH;

AMANTADINE; ANTIVIRAL AGENTS; ENTEROCOLITIS, NECROTIZING; FEMALE; HUMANS; INFANT, NEWBORN; INFLUENZA, HUMAN; OSELTAMIVIR; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY OUTCOME; RIMANTADINE;

EID: 77949909243     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e3181d44752     Document Type: Article

References (10)

1. Fiore AE, Shay DK, Broder K, Iskander JK, Uyeki TM, Mootrey G, et al; Centers for Disease Control and Prevention; Advisory Committee on Immunization Practices. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008. MMWR Recomm Rep 2008;57(RR-7):1-60.
2. Whitley RJ, Monto AS. Prevention and treatment of influenza in high-risk groups: children, pregnant women, immunocom-promised hosts, and nursing home residents. J Infect Dis 2006;194(supp 2):S133-38.
3. Naleway AL, Smith WJ, Mullooly JP. delivering influenza vaccine to pregnant women. Epidemiol Rev 2006;28:47-53.
4. Centers for Disease Control and Prevention. Pregnant women and novel influenza A (H1N1) virus: considerations for clinicians. Available at: http://www.cdc.gov/h1n1flu/clinician- pregnant.htm. Retrieved October 20, 2009.
5. Centers for Disease Control and Prevention 2009 H1N1 Influenza Shots and Pregnant Women: Questions and Answers for Patients, Available at: http://www.cdc.gov/H1N1flu/ vaccination/pregnant-qa.htm. Retrieved October 20 2009
6. Influenza vaccination and treatment during pregnancy. ACOG Committee Opinion No. 305. American College of Obstetricians and Gynecologists. Obstet Gynecol 2004;104(pt 1): 1125-1126 Reaffirmed 2006.
7. Centers for Disease Control and Prevention. Antiviral agents for seasonal influenza: side effects and adverse reactions. Available at: http://www.cdc.gov/flu/professionals/antivirals/ side-effects.htm. Retrieved October 20, 2009.
8. Rasmussen SA, Jamieson DJ, MacFarlane K, Cragan JD, Williams J, Henderson Z. Pandemic influenza and pregnant women: summary of a meeting of experts. Am J Public Health 2009;99(suppl):S248-54.
9. Koster EL, McIntire DD, Leveno KJ. Recurrence of mild malformations and dysplasias. Obstet Gynecol 2003;102: 363-366
10. Pietz J, Achanti B, Lilien L, Stepka EC, Mehta SK. Prevention of necrotizing enterocolitis in preterm infants: a 20-year experience. Pediatrics 2007;119:e164-70.